Key result
New RP-HPLC method enables simultaneous estimation of aspirin and clopidogrel in pharmaceutical dosage forms.
A new RP HPLC method was successfully developed and validated for the simultaneous estimation of aspirin and clopidogrel in tablet dosage forms.
May aid formulation quality control of dual antiplatelet agents; leaves open routine clinical lab adoption pending independent validation.
A simple and selective LC method is described for the determination of Aspirin and Clopidogrel in tablet dosage forms. Chromatographic separation was achieved on a c18 column along with mobile phase consisting of a combination of fifty five volumes of Mixed Phosphate Buffer and forty five volumes of Acetonitrile with detection of 235 nm. Linearity was observed in the range 20-60 μg/ml for Aspirin (r2=0.998) and 10-30 μg /ml for Clopidogrel (r2 =0.998) for the amount of drugs estimated by the projected ways was in smart agreement with the label claim. The proposed methods were validated. The accuracy of the methods was assessed by recovery studies at three different levels. Recovery experiments indicated the absence of interference from commonly encountered pharmaceutical additives. The method was found to be precise as indicated by the repeatability analysis, showing %RSD trials. All statistical data proves validity of the ways and may be used for routine analysis of pharmaceutical dosage form.
No takes yet. Share an insight, caveat, or question.
Sreekanth et al. (2020) studied this question. RP-HPLC method was evaluated on Method validation for simultaneous estimation of aspirin and clopidogrel. A new RP-HPLC method was successfully developed and validated for the simultaneous estimation of aspirin and clopidogrel in pharmaceutical dosage forms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: